Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for male hypogonadism are effective and should be personalized.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Obese women with PCOS are more likely to have fatty liver disease.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Spironolactone may help reduce hair loss in androgenic alopecia.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Balding men have higher heart disease risk.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.